Week 11 Heart Failure Summary.edited.docx NURS 615 Current Pharmacological Therapies In

Document Content and Description Below

Week 11 Heart Failure Summary.edited.docx NURS 615 Current Pharmacological Therapies In Heart Failure Patients Review Maryville University NURS 615: Advanced Pharmacotherapeutics For this assignm... ent, I chose the article, Current pharmacological therapies in heart failure patients. The article by Muiesan et al. (2017) examines the health and social-economic implications of heart failure in the healthcare system and the current pharmacological interventions for treating the condition. Treatment guidelines of heart failure in the United States and Europe propose clinical differentiation between heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction(HFpEF). Pharmacological interventions guidelines for HFrEF are mostly uniform in the United States and Europe. The only difference occurs in the indication to second-line agents, namely ivabradine, hydralazine-isosorbide dinitrate in t. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . [Show More]

Last updated: 1 year ago

Preview 1 out of 2 pages